feed

S&P 500—

NASDAQ—

DOW—

RUSSELL—

VIX—

US10Y—

DXY—

EUR/USD—

GBP/USD—

GOLD—

WTI—

BTC—

ETH—

AArphraTerminal

Arphra/Issuer/MANE

MANE

Veradermics, Incorporated

HealthcareBiotechnologyUSUSD

$100.91

Live · FMPMay 29, 2026

Market cap

$4.22B

52w range

32.00 – 117.71

P / E

—

EPS

—

Volume

856.09K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Veradermics, Incorporated’s valuation

Press releasestopic:all earnings guidance dividend buyback mna ipo split layoffs lawsuit regulation rating executive product macro

News sentiment · 90d

DB · scored

2026-05-12 bullish neutral bearish2026-05-12

News

DB · scored2

Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress+0.67
May 12, 2026Business Wire
Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress+0.67
May 12, 2026Business Wire